Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Data Collection I01:30

Data Collection I

7.8K
Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...
7.8K
Data Collection II01:29

Data Collection II

9.5K
The nursing history captures and records the patient's health status, so that a care plan evolves to meet the patient's individual needs. The nursing health history is a part of the initial assessment. A comprehensive history covers all health dimensions and plays a significant role in the assessment process. A comprehensive history includes the patient's biographical information, reasons for seeking health care, expectations, present and past health history, medications, and...
9.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Pharmacovigilance01:19

Pharmacovigilance

1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Managing Early-Stage Chronic Kidney Disease: A Qualitative Study of Patients' and Healthcare Professionals' Perspectives.

Nursing & health sciences·2026
Same author

Regional anaesthesia and chronic postsurgical pain: a systematic review and network meta-analysis.

British journal of anaesthesia·2026
Same author

Menopause and musculoskeletal health in English primary care: study protocol.

BJGP open·2026
Same author

Evaluating the Impact of Different Natural History Modeling Methods on Cost-Effectiveness Decisions: A Case Study in Duchenne Muscular Dystrophy.

MDM policy & practice·2026
Same author

Prioritising and ranking methodological uncertainties in the design, conduct, and analysis of trials aiming to improve health outcomes for those living with multiple long-term conditions: A protocol for a modified Delphi study.

Journal of multimorbidity and comorbidity·2026
Same author

Maintaining function and participation through tailored 24-hour movement behaviours for people living with multiple long-term conditions and frailty (The PERSONAL-AGILITY study): Protocol for a randomised controlled feasibility trial.

PloS one·2026

Related Experiment Video

Updated: Jan 8, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.5K

Patient and Public Involvement (PPI) in Secondary Data Analysis: Protocol for a Targeted Review.

Jonathan Broomfield1,2, Elizabeth Fisher1, Eleanor Booth3

  • 1Division of Public Health and Epidemiology, University of Leicester, Leicester, UK.

Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|December 18, 2025
PubMed
Summary

Patient and public involvement (PPI) in secondary data analysis research is growing, but its integration and reporting need improvement. This review assesses PPI trends in The BMJ, offering insights for enhanced public engagement in health research.

More Related Videos

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.5K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Area of Science:

  • Health Services Research
  • Research Methodology
  • Public Health

Background:

  • Patient and Public Involvement (PPI) is crucial for health research relevance and impact.
  • PPI is well-established in primary research but underexplored in secondary data analysis.
  • This review examines PPI in secondary data analysis within The BMJ.

Purpose of the Study:

  • To assess the prevalence, characteristics, and evolution of PPI in secondary data analysis studies.
  • To identify trends in PPI reporting before and after The BMJ's 2015 PPI mandate.
  • To summarize current practices and identify effective PPI strategies in secondary data research.

Main Methods:

  • Targeted literature review of The BMJ articles from 2014, 2019, and 2024.
  • Inclusion criteria: original research using secondary data.
  • Data extraction on study characteristics and PPI outcomes; quantitative and qualitative analysis; public contributor feedback on PPI statements.

Main Results:

  • Analysis of PPI prevalence and trends in secondary data analysis studies.
  • Qualitative summary of PPI reporting practices.
  • Feedback from public contributors on the quality of PPI integration and reporting.

Conclusions:

  • Findings will inform best practices for meaningful PPI in secondary data research.
  • Dissemination through publications, conferences, and community engagement.
  • Promoting inclusivity and impact in health research through enhanced PPI.